pillbase.ru

Icatibant

Active substance: icatibant

INJECTION · ICATIBANT ACETATE 30 mg/3mL

United StatesActive

Marketing holder: Alembic Pharmaceuticals Limited

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 2
  • Firazyr
    icatibant
    EMEA/H/C/000899
    Takeda Pharmaceuticals International AG
  • Icatibant Accord
    icatibant acetate
    EMEA/H/C/005083
    Accord Healthcare S.L.U.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-4d21-7ada-9c1a-f499e792ab3a,01a1208c-74e5-7675-8f35-9ebf7ea53a40,01a1208c-abf9-7e6c-806b-e81027ac8659,01a1208d-428b-7e98-a2b0-f5f8d0541075,01a1208e-9c6d-7130-a9d9-79257963078d;count=9 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
46708-654
Registration status
Active
Dispensing
Prescription only
Route
SUBCUTANEOUS
Sources
  • product · openFDA NDC · 46708-654 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 46708-654 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 46708-654 · Verified 2026-10-09 · open in source